THERESE Study ((The influence of heart failure with preserved ejection fraction on 2-year mortality in patients with chronic obstructive pulmonary disease) – multicentric, prospective, case-control trial protocol).

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73603366" target="_blank" >RIV/61989592:15110/20:73603366 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.pneumologie.cz/cislo/1747/4-2020/" target="_blank" >http://www.pneumologie.cz/cislo/1747/4-2020/</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

THERESE Study ((The influence of heart failure with preserved ejection fraction on 2-year mortality in patients with chronic obstructive pulmonary disease) – multicentric, prospective, case-control trial protocol).

Popis výsledku v původním jazyce

Introduction: Heart failure with preserved ejection fraction (HFpEF) is highly prevalent among patients with chronic obstructive pulmonary disease (COPD). It could possibly negatively influence mortality of COPD patients but currently, robust data are missing. Aim: The aim of THERESE study (The influence of hearT failure with preserved ejection fraction on 2-year mortality of patients with cHronic obstructivE pulmonaRy disEaSE) is to assess the potential influence of HFpEF on mortality of COPD patients in stages C and D according to Global Initiative for Obstructive Lung Disease (GOLD) criteria. Methods: This is a multicentric, prospective case-control study where we are 150 patients. Discussion: The data from THERESE study will provide us with information about possible influence of HFpEF on mortality of patients with COPD. This could be important in the future management of COPD patients as the potentially immediate diagnosis of HFpEF and its subsequent treatment o fit could improve the patients prognosis. We will also have available data about the prevalence of HFpEF among different COPD phenotypes as this is the secondary endpoint of this study. Study Registration: ClinicalTrials.gov Identifier: NCT04277429

Název v anglickém jazyce

THERESE Study ((The influence of heart failure with preserved ejection fraction on 2-year mortality in patients with chronic obstructive pulmonary disease) – multicentric, prospective, case-control trial protocol).

Popis výsledku anglicky

Introduction: Heart failure with preserved ejection fraction (HFpEF) is highly prevalent among patients with chronic obstructive pulmonary disease (COPD). It could possibly negatively influence mortality of COPD patients but currently, robust data are missing. Aim: The aim of THERESE study (The influence of hearT failure with preserved ejection fraction on 2-year mortality of patients with cHronic obstructivE pulmonaRy disEaSE) is to assess the potential influence of HFpEF on mortality of COPD patients in stages C and D according to Global Initiative for Obstructive Lung Disease (GOLD) criteria. Methods: This is a multicentric, prospective case-control study where we are 150 patients. Discussion: The data from THERESE study will provide us with information about possible influence of HFpEF on mortality of patients with COPD. This could be important in the future management of COPD patients as the potentially immediate diagnosis of HFpEF and its subsequent treatment o fit could improve the patients prognosis. We will also have available data about the prevalence of HFpEF among different COPD phenotypes as this is the secondary endpoint of this study. Study Registration: ClinicalTrials.gov Identifier: NCT04277429

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30203 - Respiratory systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Studia Pneumologica et Phthiseologica

ISSN

1213-810X

e-ISSN

—

Svazek periodika

80

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

170-174

Kód UT WoS článku

—

EID výsledku v databázi Scopus

999